Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Plant Health Care plc
  6. Summary
    PHC   GB00B01JC540

PLANT HEALTH CARE PLC

(PHC)
  Report
Delayed London Stock Exchange  -  11:35:09 2023-01-27 am EST
11.20 GBX   +1.36%
01/18Plant Health Care plc Announces Board Appointments
CI
01/12Plant Health Care and Novozymes sign Harpin distribution deal in India
AN
01/12Plant Health Care Signs Distribution Deal with Novozymes to Sell Harpin in India
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
01/23/2023 01/24/2023 01/25/2023 01/26/2023 01/27/2023 Date
11.525(c) 11.575(c) 11.6(c) 11.05(c) 11.2(c) Last
27 808 283 945 43 650 350 405 264 735 Volume
+3.13% +0.43% +0.22% -4.74% +1.36% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 11,4 M - -
Net income 2022 -3,70 M - -
Net cash position 2022 4,90 M - -
P/E ratio 2022 -11,6x
Yield 2022 -
Sales 2023 15,9 M - -
Net income 2023 -1,00 M - -
Net cash position 2023 3,10 M - -
P/E ratio 2023 -46,2x
Yield 2023 -
Capitalization 42,6 M 42,6 M -
EV / Sales 2022 3,30x
EV / Sales 2023 2,48x
Nbr of Employees -
Free-Float 46,7%
More Financials
Company
Plant Health Care plc is a provider of biological products and technology solutions. The Company is focused on improving crop performance by activating a growth response and bolstering plant defense mechanisms against both abiotic and biotic stresses. Its segments include Americas, Mexico, and Rest of World. Its biological products help growers to protect their crops from stress and diseases, and to produce quality... 
More about the company
Ratings of Plant Health Care plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about PLANT HEALTH CARE PLC
01/18Plant Health Care plc Announces Board Appointments
CI
01/12Plant Health Care and Novozymes sign Harpin distribution deal in India
AN
01/12Plant Health Care Signs Distribution Deal with Novozymes to Sell Harpin in India
MT
01/12Plant Health Care plc and Novozymes South Asia Pvt. Ltd. Announce Distribution Agreemen..
CI
2022Plant Health Care plc Announces New Products Submitted for Regulatory Approval
CI
2022Plant Health Care makes strides in Europe with Portuguese deal
AN
2022Plant Health Care Registers Product for Fertilizer Use in France
MT
2022Plant Health Signs Distributor for Fertilizer PREzym in Portugal
MT
2022Plant Health Care plc Announces New Distribution Agreement with EDAF
CI
2022Plant Health Care plc Announces Registration of Harpin in France
CI
2022TRADING UPDATES: Gusbourne toasts vintage; Hardide supplies Leonardo
AN
2022Plant Health Care plc Provides Earnings Guidance for the Full Year 2022
CI
2022Earnings Flash (PHC.L) PLANT HEALTH CARE Posts H1 Loss $-0.01
MT
2022Plant Health Care plc Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022Plant Health Care to Conduct Field Trials for Plant Technology Platform
MT
More news
News in other languages on PLANT HEALTH CARE PLC
01/18Plant Health Care plc annonce des nominations au conseil d'administration
01/12Plant Health Care et Novozymes signent un accord de distribution de Harpin en Inde
01/12Plant Health Care signe un accord de distribution avec Novozymes pour vendre Harpin en ..
01/12Plant Health Care plc et Novozymes South Asia Pvt. Ltd. annoncent un accord de distribu..
2022Plant Health Care plc annonce de nouveaux produits soumis à l'approbation réglementaire
More news
Chart PLANT HEALTH CARE PLC
Duration : Period :
Plant Health Care plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PLANT HEALTH CARE PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,14 $
Average target price 0,40 $
Spread / Average Target 190%
EPS Revisions
Managers and Directors
Jeff Tweedy Chief Executive Officer & Executive Director
Jeff Hovey Chief Financial Officer & Executive Director
Christopher Gareth Joseph Richards Non-Executive Chairman
Zhong Min Wei Chief Scientific Officer & VP-Harpin Technology
William M. Lewis Independent Non-Executive Director
Sector and Competitors